Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer

Annals of Oncology

Volumn 26, Issue 2, 2015, Pages 332-339

  Sunakawa, Y ^a   Stremitzer, S ^a   Cao, S ^a   Zhang, W ^a   Yang, D ^a   Wakatsuki, T ^a   Ning, Y ^a   Yamauchi, S ^a   Stintzing, S ^a   Sebio, A ^a   El Khoueiry, R ^a   Matsusaka, S ^a   Parekh, A ^a   Barzi, A ^a   Azuma, M ^b   Watanabe, M ^b   Koizumi, W ^b   Lenz, Heinz Josef ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CCL2; Ethnic difference; Gastric cancer; NF B; Single nucleotide polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR RELA; CCL2 PROTEIN, HUMAN; CCR2 PROTEIN, HUMAN; RELA PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CCL2 GENE; CCR2 GENE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA DETERMINATION; DNA SEQUENCE; ETHNIC DIFFERENCE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAPANESE (PEOPLE); LOWER ESOPHAGUS SPHINCTER; MACROPHAGE FUNCTION; MAJOR CLINICAL STUDY; MALE; NFKB1 GENE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RELA GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; UNITED STATES; GENETICS; IMMUNOLOGY; KAPLAN MEIER METHOD; MACROPHAGE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; STOMACH TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMOKINE CCL2; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; MACROPHAGES; MALE; MIDDLE AGED; NF-KAPPA B; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CCR2; STOMACH NEOPLASMS; TRANSCRIPTION FACTOR RELA;

EID: 84925334953     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu542     Document Type: Article

References (24)

1. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124: 263-266.
2. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964.
3. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 2011; 12: 715-723.
4. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009; 29: 313-326.
5. Pomerantz JL, Baltimore D. Two pathways to NF-kappaB. Mol Cell 2002; 10: 693-695.
6. Lee BL, Lee HS, Jung J et al. Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer. Clin Cancer Res 2005; 11: 2518-2525.
7. Tao LL, Shi SJ, Chen LB et al. Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia. World J Gastroenterol 2014; 20: 4421-4427.
8. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14: 101-112.
9. Lauren P. The two histological main types of gastric carcinoma: diffuse and socalled intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
10. Lee PH, Shatkay H. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 2008; 36: D820-D824.
11. Sasaki N, Morisaki T, Hashizume K et al. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 2001; 7: 4136-4142.
12. Shah MA, Kelsen DP. Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw 2010; 8: 437-447.
13. Shah MA, Khanin R, Tang L et al. Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res 2011; 17: 2693-2701.
14. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362.
15. Tan IB, Ivanova T, Lim KH et al. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology 2011; 141: 476-485, 485.e471-485.e411.
16. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014; 513: 202-209.
17. Dooley CP, Cohen H, Fitzgibbons PL et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562-1566.
18. Asaka M, Kimura T, Kudo M et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102: 760-766.
19. Jia LQ, Shen YC, Guo SJ et al. The 2518 A/G polymorphism in the MCP-1 gene and cancer risk: a meta-analysis. Asian Pac J Cancer Prev 2013; 14: 3575-3579.
20. Coussens AK, Wilkinson RJ, Nikolayevskyy V et al. Ethnic variation in inflammatory profile in tuberculosis. PLoS Pathog 2013; 9: e1003468.
21. Roca H, Varsos Z, Pienta KJ. CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin upregulation. J Biol Chem 2008; 283: 25057-25073.
22. Wakatsuki T, Zhang W, Yang DY et al. Ethnic gene profile of genes involved in angiogenesis to predict regional bevacizumab efficacy difference in gastric cancer. J Clin Oncol 2012; 30(Suppl): (abstr 4026).
23. Xu B, Feng NH, Tong N et al. VEGF-460C>T polymorphism and cancer risk: a meta-analysis. Med Oncol 2010; 27: 1031-1036.
24. Chong ML, Loh M, Thakkar B et al. Phosphatidylinositol-3-kinase pathway aberrations in gastric and colorectal cancer: meta-analysis, co-occurrence and ethnic variation. Int J Cancer 2014; 134: 1232-1238.